A nurse is educating a group of healthcare professionals about blood transfusion safety measures.
Which of the following actions should the nurse include as part of these safety measures? (Select all that apply)
Ensuring blood products meet quality and safety standards.
Using the right blood product for the right patient at the right time.
Applying a barcode system or electronic verification system for patient and product identification.
Administering blood products using reusable equipment.
Disposing of used blood products and materials according to hospital policy.
Correct Answer : A,B,C,E
Choice A rationale:
Ensuring that blood products meet quality and safety standards is a fundamental aspect of blood transfusion safety.
Blood products must be properly screened and tested for infectious diseases and compatibility to reduce the risk of adverse reactions in the recipient.
Choice B rationale:
Using the right blood product for the right patient at the right time is a critical safety measure.
Administering the wrong blood type or product can lead to severe and life-threatening reactions, such as hemolytic transfusion reactions.
Choice C rationale:
Applying a barcode system or electronic verification system for patient and product identification is essential for ensuring that the correct blood product is matched to the right patient.
This technology helps prevent administration errors.
Choice D rationale:
Administering blood products using reusable equipment is not recommended due to the risk of cross-contamination and infection transmission.
Single-use, disposable equipment is the standard for blood transfusion to enhance safety.
Choice E rationale:
Disposing of used blood products and materials according to hospital policy is crucial to prevent potential contamination and reduce the risk of infection transmission.
Proper disposal procedures are a part of overall transfusion safety protocols.
Choice D is not a recommended safety measure as using reusable equipment for blood transfusions can increase the risk of contamination and transmission of infections.
Therefore, it should not be included as part of blood transfusion safety measures.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A rationale:
"I can receive blood from donors with blood types A-, O+, or O-." Rationale: This statement is incorrect because individuals with blood type A- can only receive blood from donors with blood type A- or O-.
Rh factor (positive or negative) is a critical consideration in blood compatibility.
Choice B rationale:
"I can receive blood from donors with blood types A- or O-." Rationale: This statement is accurate.
Individuals with blood type A- can safely receive blood from donors with blood type A- (the same type) or O- (universal donor for A- individuals)
The negative Rh factor ensures compatibility.
Choice C rationale:
"I can receive blood from donors with blood types A-, A+, O+, or O-." Rationale: This statement is incorrect.
Individuals with blood type A- should not receive blood from donors with A+ because the Rh factor is incompatible.
A- individuals can only safely receive Rh-negative blood.
Choice D rationale:
"I can receive blood from donors with blood types A-, A+, or O-." Rationale: This statement is incorrect because it suggests that an A- individual can receive blood from A+ donors.
As mentioned earlier, the Rh factor must be compatible, and A- individuals should not receive Rh-positive blood.
Correct Answer is C
Explanation
Choice A rationale:
Oxygen therapy is not a medication used to promote clotting or stop bleeding.
Its primary purpose is to improve oxygen delivery to tissues, especially in cases of hypoxia.
Choice B rationale:
Erythropoietin injections are used to stimulate red blood cell production in conditions like anemia.
While it can indirectly help improve oxygen-carrying capacity, it does not promote clotting or stop bleeding.
Choice C rationale:
Hemostatic agents like vitamin K or tranexamic acid can help promote clotting and stop bleeding.
Vitamin K is essential for the synthesis of clotting factors in the liver, while tranexamic acid is an antifibrinolytic agent that prevents the breakdown of clots.
These medications are often used in bleeding disorders to control hemorrhage.
Choice D rationale:
Iron therapy is used to treat iron-deficiency anemia and increase hemoglobin levels.
It does not have a direct role in promoting clotting or stopping bleeding.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.